Iovance Biotherapeutics Inc (IOVA)
2.955
-0.30
(-9.08%)
USD |
NASDAQ |
Apr 04, 10:34
Iovance Biotherapeutics Profit Margin (Quarterly): -106.6% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Viatris Inc | -14.64% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 12.11% |
| Xtant Medical Holdings Inc | -10.04% |
| VolitionRX Ltd | -3.02K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -52.91% |
| Return on Assets | -41.21% |
| Return on Invested Capital | -52.84% |
| Gross Profit Margin (Quarterly) | 38.20% |
| Operating Margin (Quarterly) | -117.5% |
| Return on Net Operating Assets | -71.73% |